XML 21 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash Flows from Operating Activities:    
Net loss $ (3,287,711) $ (5,973,132)
Adjustments to reconcile net loss to net cash used in operations:    
Amortization of right-to-use asset 101,843 0
Change in fair value of convertible note 23,000 0
Penalty on convertible note 37,500 0
Amortization of discount – PIK Notes 381,323 361,813
Amortization of discount – notes payable 6,250 0
Amortization of deferred financing costs 6,250 424,690
Accrued interest on PIK Notes 1,370,005 1,338,671
Stock-based compensation expense 75,669 249,116
Non-cash lease expense 0 3,657
Change in operating assets and liabilities:    
Accounts receivable 10,751 (45,654)
Deposits and prepaid expenses 312,584 351,883
Operating lease liability (101,487) 0
Accounts payable and accrued expenses 909,146 908,629
Deferred revenue 1,000,000 0
Net cash provided by (used in) operating activities 845,123 (2,380,327)
Cash Flows from Financing Activities:    
Payment of insurance financing (295,556) (302,652)
Proceeds from notes payable – related party 0 200,000
Payments on notes payable (394,625)  
Payments on PIK notes 0 (356,568)
Proceeds from private placement 125,000 0
Proceeds from Paycheck Protection Program Loan 223,075 0
Proceeds from notes payable 113,750 0
Net cash (used in) financing activities (228,356) (459,220)
Net (decrease) increase in cash and cash equivalents 616,767 (2,839,547)
Cash and cash equivalents at beginning of year 52,793 2,892,340
Cash and cash equivalents at end of year 669,560 52,793
Supplemental disclosure of cash flow information:    
Cash paid for interest 4,395 12,982
Cash paid for income taxes 0 0
Supplemental disclosure of non-cash financing activity:    
Notes payable – insurance financing 219,538 259,827
Capitalization of right to use assets and liabilities 0 241,808
Accrued PIK interest paid through issuance of PIK Notes 1,181,787 1,505,578
Deemed dividend on Convertible Series B Preferred Stock 81,836 0
Common stock issued to note holders for financing cost 1,250 0
Common stock issued upon conversion of note payable 40,504  
Accounting Standards Update 2017-11 [Member]    
Supplemental disclosure of non-cash financing activity:    
Effect of ASU 2017-11, Financial Instruments with Characteristics of Liabilities and Equity and ASU 2016-02, Leases $ 0 $ 4,941,447